ArticleEuropean journal of hospital pharmacy : science and practice2024

Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years.

Alessia Romagnoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.